{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:46:53Z","timestamp":1785732413259,"version":"3.56.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) has been associated with elevated mortality risk and cardiovascular disease incident among the general population. However, evidence on its impact among breast cancer (BC) survivors remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BC survivors in the UK Biobank, a large-scale, population-based prospective cohort, were included in this study. MetS was defined as fulfilling at least three of the following criteria: (1) central obesity, (2) elevated triglycerides or taking lipid-lowering medication, (3) increased blood pressure, (4) elevated fasting blood glucose, and (5) reduced HDL cholesterol. The primary outcome was all-cause mortality, while the secondary outcomes were comorbidity incident. The associations between MetS with mortality and comorbidity incident were determined using Cox proportional regression by quantifying the hazard ratio (HR) and its 95% confidence interval (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After a median follow-up of 15.7 (interquartile range, 15.1 to 16.4) years, a total of 1,251 deaths were observed among 6,027 BC survivors, of whom 1,997 (33.1%) had MetS. MetS was significantly associated with all-cause mortality (HR, 1.23; 95% CI, 1.08 to 1.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.002). Meanwhile, MetS was also significantly associated with elevated risk of myocardial infarction (MI; HR, 1.56; 95% CI, 1.02 to 2.40), atrial fibrillation (AF; HR, 1.61; 95% CI, 1.04 to 2.49), and chronic kidney disease (CKD; HR, 1.98 95% CI, 1.56 to 2.51) incident. Fatty acid metabolism and inflammation were identified as the potential mediating factors between MetS and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MetS was significantly associated with elevated mortality risk and incident of MI, AF, and CKD. The MetS\u2013mortality association was potentially mediated by fatty acid metabolism and inflammation. Findings highlighted MetS as a potentially modifiable risk factor in BC survivors, underscoring the need for targeted metabolic management to improve long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1854729","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:27:48Z","timestamp":1785731268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between metabolic syndrome and mortality among breast cancer survivors: a prospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, Shaoxing Shangyu People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Shaoxing Shangyu People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Shaoxing Shangyu People\u2019s Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.14341\/2071-8713-5281","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2010.02.011","article-title":"The metabolic syndrome in older persons","volume":"26","author":"Sinclair","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67781-1","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.04.036","article-title":"Metabolic syndrome-associated kidney disease in young adolescents and children","volume":"108","author":"Raina","year":"2025","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/jco.2015.64.3809","article-title":"American cancer society\/american society of clinical oncology breast cancer survivorship care guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071565","article-title":"Advances in the care of breast cancer survivors","volume":"382","author":"Cathcart-Rake","year":"2023","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102375","article-title":"Adjuvant and neoadjuvant breast cancer treatments: a systematic review of their effects on mortality","volume":"105","author":"Kerr","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.65.9573","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression","volume":"34","author":"Burstein","year":"2016","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-642-04231-7_8","article-title":"Physical activity and breast cancer survivorship","volume":"186","author":"Schmitz","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174414","article-title":"Depression, inflammation, and intestinal permeability: associations with subjective and objective cognitive functioning throughout breast cancer survivorship","volume":"15","author":"Madison","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlpt.2012.07.003","article-title":"UK Biobank: current status and what it means for epidemiology","volume":"1","author":"Allen","year":"2012","journal-title":"Health Policy Technol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/joim.20052","article-title":"Metabolic syndrome is associated with breast cancer mortality: a systematic review and meta-analysis","volume":"297","author":"Harborg","year":"2025","journal-title":"J Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.75.7526","article-title":"Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial","volume":"36","author":"Dieli-Conwright","year":"2018","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102983","article-title":"Dietary strategies for metabolic syndrome: a comprehensive review","volume":"12","author":"Castro-Barquero","year":"2020","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071652","article-title":"Physical activity, cardiorespiratory fitness, and the metabolic syndrome","volume":"11","author":"Myers","year":"2019","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13443","article-title":"Metabolic syndrome and cardiovascular disease in cancer survivors","volume":"15","author":"Ueno","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1519925","article-title":"The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1139\/h07-087","article-title":"Inflammation, obesity, and fatty acid\u00a0metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing\u00a0to\u00a0metabolic syndrome","volume":"32","author":"Robinson","year":"2007","journal-title":"Appl Physiol Nutr Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113232","article-title":"Diet quality, saturated fat and metabolic syndrome","volume":"12","author":"Harrison","year":"2020","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1079\/pns2004405","article-title":"Fatty acids and the metabolic syndrome","volume":"64","author":"Roche","year":"2005","journal-title":"Proc Nutr Soc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf146","article-title":"Accelerometer-derived concentrated physical activity pattern and mortality in cancer survivors: the UK Biobank accelerometry study","volume":"118","author":"Shi","year":"2026","journal-title":"J Natl Cancer Inst"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1854729\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:27:49Z","timestamp":1785731269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1854729\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1854729"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1854729","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1854729"}}